Cargando…
Inactivation of the CB(2) receptor accelerated the neuropathological deterioration in TDP‐43 transgenic mice, a model of amyotrophic lateral sclerosis
The activation of the cannabinoid receptor type‐2 (CB(2)) afforded neuroprotection in amyotrophic lateral sclerosis (ALS) models. The objective of this study was to further investigate the relevance of the CB(2) receptor through investigating the consequences of its inactivation. TDP‐43(A315T) trans...
Autores principales: | Rodríguez‐Cueto, Carmen, Gómez‐Almería, Marta, García Toscano, Laura, Romero, Julián, Hillard, Cecilia J., de Lago, Eva, Fernández‐Ruiz, Javier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8549023/ https://www.ncbi.nlm.nih.gov/pubmed/33983653 http://dx.doi.org/10.1111/bpa.12972 |
Ejemplares similares
-
Clinical Significance of TDP-43 Neuropathology in Amyotrophic Lateral Sclerosis
por: Cykowski, Matthew D., et al.
Publicado: (2017) -
TDP-43—The key to understanding amyotrophic lateral sclerosis
por: Xu, Zuoshang, et al.
Publicado: (2014) -
The role of TDP-43 mislocalization in amyotrophic lateral sclerosis
por: Suk, Terry R., et al.
Publicado: (2020) -
Molecular Neuropathology of TDP-43 Proteinopathies
por: Neumann, Manuela
Publicado: (2009) -
TDP-43 and Phosphorylated TDP-43 Levels in Paired Plasma and CSF Samples in Amyotrophic Lateral Sclerosis
por: Ren, Yuting, et al.
Publicado: (2021)